Jörgen Jonsson

Integrative transcriptomic meta-analysis reveals immune, synaptic, and non-coding RNA dysregulation in bipolar disorder across brain and blood

Panina, Aleksandra; Sokolov, Aleksandr V.; Jonsson, Jörgen; Fredriksson, Robert et al.

Ingår i Neurobiology of Disease, 2026

• DOI för Integrative transcriptomic meta-analysis reveals immune, synaptic, and non-coding RNA dysregulation in bipolar disorder across brain and blood
• Ladda ner fulltext (pdf) av Integrative transcriptomic meta-analysis reveals immune, synaptic, and non-coding RNA dysregulation in bipolar disorder across brain and blood

Statin drugs and lipid modulation: Mechanistic basis considering lipid rafts, kinase signaling, myopathy, and cancer

Karthikeyan, Suditi; Somasundaram, Poornima; Karimi, Isaac; Lagunas-Rangel, Francisco Alejandro et al.

Ingår i Pharmacological Research, 2025

• DOI för Statin drugs and lipid modulation: Mechanistic basis considering lipid rafts, kinase signaling, myopathy, and cancer
• Ladda ner fulltext (pdf) av Statin drugs and lipid modulation: Mechanistic basis considering lipid rafts, kinase signaling, myopathy, and cancer

Statins regulate kinase signaling by causing changes in phosphorylation, rather than through changes in gene expression or direct inhibition: evidence in colorectal cancer

Lagunas-Rangel, Francisco Alejandro; Jonsson, Jörgen; Jackevica, Ludmila; Fredriksson, Robert et al.

Ingår i Frontiers in Pharmacology, 2025

• DOI för Statins regulate kinase signaling by causing changes in phosphorylation, rather than through changes in gene expression or direct inhibition: evidence in colorectal cancer
• Ladda ner fulltext (pdf) av Statins regulate kinase signaling by causing changes in phosphorylation, rather than through changes in gene expression or direct inhibition: evidence in colorectal cancer

Ketamine and Esketamine in Clinical Trials: FDA‐Approved and Emerging Indications, Trial Trends With Putative Mechanistic Explanations

Vekhova, Ksenia A.; Namiot, Eugenia D.; Jonsson, Jörgen; Schiöth, Helgi

Ingår i Clinical Pharmacology and Therapeutics, s. 374-386, 2025

• DOI för Ketamine and Esketamine in Clinical Trials: FDA‐Approved and Emerging Indications, Trial Trends With Putative Mechanistic Explanations
• Ladda ner fulltext (pdf) av Ketamine and Esketamine in Clinical Trials: FDA‐Approved and Emerging Indications, Trial Trends With Putative Mechanistic Explanations

Off-target effects of statins: molecular mechanisms, side effects and the emerging role of kinases

Lagunas-Rangel, Francisco Alejandro; Liepinsh, Edgars; Fredriksson, Robert; Alsehli, Ahmed M. et al.

Ingår i British Journal of Pharmacology, s. 3799-3818, 2024

• DOI för Off-target effects of statins: molecular mechanisms, side effects and the emerging role of kinases
• Ladda ner fulltext (pdf) av Off-target effects of statins: molecular mechanisms, side effects and the emerging role of kinases

Integrative transcriptomic meta-analysis reveals immune, synaptic, and non-coding RNA dysregulation in bipolar disorder across brain and blood

Panina, Aleksandra; Sokolov, Aleksandr V.; Jonsson, Jörgen; Fredriksson, Robert et al.

Ingår i Neurobiology of Disease, 2026

• DOI för Integrative transcriptomic meta-analysis reveals immune, synaptic, and non-coding RNA dysregulation in bipolar disorder across brain and blood
• Ladda ner fulltext (pdf) av Integrative transcriptomic meta-analysis reveals immune, synaptic, and non-coding RNA dysregulation in bipolar disorder across brain and blood

Statin drugs and lipid modulation: Mechanistic basis considering lipid rafts, kinase signaling, myopathy, and cancer

Karthikeyan, Suditi; Somasundaram, Poornima; Karimi, Isaac; Lagunas-Rangel, Francisco Alejandro et al.

Ingår i Pharmacological Research, 2025

• DOI för Statin drugs and lipid modulation: Mechanistic basis considering lipid rafts, kinase signaling, myopathy, and cancer
• Ladda ner fulltext (pdf) av Statin drugs and lipid modulation: Mechanistic basis considering lipid rafts, kinase signaling, myopathy, and cancer

Statins regulate kinase signaling by causing changes in phosphorylation, rather than through changes in gene expression or direct inhibition: evidence in colorectal cancer

Lagunas-Rangel, Francisco Alejandro; Jonsson, Jörgen; Jackevica, Ludmila; Fredriksson, Robert et al.

Ingår i Frontiers in Pharmacology, 2025

• DOI för Statins regulate kinase signaling by causing changes in phosphorylation, rather than through changes in gene expression or direct inhibition: evidence in colorectal cancer
• Ladda ner fulltext (pdf) av Statins regulate kinase signaling by causing changes in phosphorylation, rather than through changes in gene expression or direct inhibition: evidence in colorectal cancer

Ketamine and Esketamine in Clinical Trials: FDA‐Approved and Emerging Indications, Trial Trends With Putative Mechanistic Explanations

Vekhova, Ksenia A.; Namiot, Eugenia D.; Jonsson, Jörgen; Schiöth, Helgi

Ingår i Clinical Pharmacology and Therapeutics, s. 374-386, 2025

• DOI för Ketamine and Esketamine in Clinical Trials: FDA‐Approved and Emerging Indications, Trial Trends With Putative Mechanistic Explanations
• Ladda ner fulltext (pdf) av Ketamine and Esketamine in Clinical Trials: FDA‐Approved and Emerging Indications, Trial Trends With Putative Mechanistic Explanations

Off-target effects of statins: molecular mechanisms, side effects and the emerging role of kinases

Lagunas-Rangel, Francisco Alejandro; Liepinsh, Edgars; Fredriksson, Robert; Alsehli, Ahmed M. et al.

Ingår i British Journal of Pharmacology, s. 3799-3818, 2024

• DOI för Off-target effects of statins: molecular mechanisms, side effects and the emerging role of kinases
• Ladda ner fulltext (pdf) av Off-target effects of statins: molecular mechanisms, side effects and the emerging role of kinases

Depression proteomic profiling in adolescents with transcriptome analyses in independent cohorts

Sokolov, Aleksandr V.; Lafta, Muataz; Nordberg, Didi; Jonsson, Jörgen et al.

Ingår i Frontiers in Psychiatry, 2024

• DOI för Depression proteomic profiling in adolescents with transcriptome analyses in independent cohorts
• Ladda ner fulltext (pdf) av Depression proteomic profiling in adolescents with transcriptome analyses in independent cohorts

Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales

Bondarev, Andrey D.; Jonsson, Jörgen; Chubarev, Vladimir N.; V. Tarasov, Vadim et al.

Ingår i Pharmacological Research, 2024

• DOI för Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales
• Ladda ner fulltext (pdf) av Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales

Recent developments of HDAC inhibitors: Emerging indications and novel molecules

Bondarev, Andrey D; Attwood, Misty M.; Jonsson, Jörgen; Chubarev, Vladimir N et al.

Ingår i British Journal of Clinical Pharmacology, s. 4577-4597, 2021

• DOI för Recent developments of HDAC inhibitors: Emerging indications and novel molecules
• Ladda ner fulltext (pdf) av Recent developments of HDAC inhibitors: Emerging indications and novel molecules

meQTL and ncRNA functional analyses of 102 GWAS-SNPs associated with depression implicate HACE1 and SHANK2 genes

Ciuculete, Diana-Maria; Voisin, Sarah; Kular, Lara; Jonsson, Jörgen et al.

Ingår i Clinical Epigenetics, 2020

• DOI för meQTL and ncRNA functional analyses of 102 GWAS-SNPs associated with depression implicate HACE1 and SHANK2 genes
• Ladda ner fulltext (pdf) av meQTL and ncRNA functional analyses of 102 GWAS-SNPs associated with depression implicate HACE1 and SHANK2 genes

A pharmacogenetic risk score for the evaluation of major depression severity under treatment with antidepressants

Kanders, Sofia H.; Pisanu, Claudia; Bandstein, Marcus; Jonsson, Jörgen et al.

Ingår i Drug development research, s. 102-113, 2020

• DOI för A pharmacogenetic risk score for the evaluation of major depression severity under treatment with antidepressants
• Ladda ner fulltext (pdf) av A pharmacogenetic risk score for the evaluation of major depression severity under treatment with antidepressants

Longitudinal DNA methylation changes at MET may alter HGF/c-MET signalling in adolescents at risk for depression

Ciuculete, Diana Maria; Voisin, Sarah; Kular, Lara; Welihinda, Nipuni et al.

Ingår i Epigenetics, s. 646-663, 2020

• DOI för Longitudinal DNA methylation changes at MET may alter HGF/c-MET signalling in adolescents at risk for depression
• Ladda ner fulltext (pdf) av Longitudinal DNA methylation changes at MET may alter HGF/c-MET signalling in adolescents at risk for depression

SLC10A4 regulates IgE-mediated mast cell degranulation in vitro and mast cell-mediated reactions in vivo

Pettersson, Hanna; Zarnegar, Behdad; Westin, Annika; Persson, Viktor et al.

Ingår i Scientific Reports, 2017

• DOI för SLC10A4 regulates IgE-mediated mast cell degranulation in vitro and mast cell-mediated reactions in vivo
• Ladda ner fulltext (pdf) av SLC10A4 regulates IgE-mediated mast cell degranulation in vitro and mast cell-mediated reactions in vivo

Conditional targeting of medium spiny neurons in the striatal matrix

Reinius, Björn; Blunder, Martina; Brett, Frances M.; Eriksson, Anders et al.

Ingår i Frontiers in Behavioral Neuroscience, 2015

• DOI för Conditional targeting of medium spiny neurons in the striatal matrix
• Ladda ner fulltext (pdf) av Conditional targeting of medium spiny neurons in the striatal matrix

Dissecting the Molecular Mechanisms Surrounding Post-COVID-19 Syndrome and Neurological Features

Mohamed, Mohamed S.; Johansson, Anton; Jonsson, Jörgen; Schiöth, Helgi B.

Ingår i International Journal of Molecular Sciences, 2022

• DOI för Dissecting the Molecular Mechanisms Surrounding Post-COVID-19 Syndrome and Neurological Features
• Ladda ner fulltext (pdf) av Dissecting the Molecular Mechanisms Surrounding Post-COVID-19 Syndrome and Neurological Features

Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules

Bondarev, Andrey D.; Attwood, Misty M.; Jonsson, Jörgen; Chubarev, Vladimir N. et al.

Ingår i Frontiers in Pharmacology, 2022

• DOI för Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules
• Ladda ner fulltext (pdf) av Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules

Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales

Dahlén, Amelia; Dashi, Giovanna; Maslov, Ivan; Attwood, Misty M. et al.

Ingår i Frontiers in Pharmacology, 2022

• DOI för Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales
• Ladda ner fulltext (pdf) av Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales

Role of the synergistic interactions of environmental pollutants in the development of cancer

Lagunas-Rangel, Francisco Alejandro; Niemi, Jenni Viivi Linnea; Kudłak, Błażej; Williams, Michael J. et al.

Ingår i GeoHealth, 2022

• DOI för Role of the synergistic interactions of environmental pollutants in the development of cancer
• Ladda ner fulltext (pdf) av Role of the synergistic interactions of environmental pollutants in the development of cancer

Soluble ligands as drug targets

Attwood, Misty M.; Jonsson, Jörgen; Rask-Andersen, Mathias; Schiöth, Helgi B.

Ingår i Nature reviews. Drug discovery, s. 695-710, 2020

• DOI för Soluble ligands as drug targets

Opportunities and challenges for drug discovery in modulating Adhesion G protein-coupled receptor (GPCR) functions

Bondarev, Andrey D.; Attwood, Misty M.; Jonsson, Jörgen; Chubarev, Vladimir N. et al.

Ingår i Expert Opinion on Drug Discovery, s. 1291-1307, 2020

• DOI för Opportunities and challenges for drug discovery in modulating Adhesion G protein-coupled receptor (GPCR) functions
• Ladda ner fulltext (pdf) av Opportunities and challenges for drug discovery in modulating Adhesion G protein-coupled receptor (GPCR) functions

Statins inhibit neurite outgrowth and induce morphological changes in cellular compartments in maturing neurons derived from human neural stem cells

Hosseini, Kimia; Ceder, Mikaela M.; Jonsson, Jörgen; Schiöth, Helgi et al.